— Know what they know.
Not Investment Advice
Also trades as: WGSWW (NASDAQ) · $vol 0M

WGS NASDAQ

GeneDx Holdings Corp.
1W: +21.8% 1M: -32.2% 3M: -42.3% YTD: -64.2% 1Y: -34.4% 3Y: +650.1% 5Y: -87.1%
$47.31
-0.02 (-0.04%)
 
Weekly Expected Move ±27.4%
$18 $30 $41 $52 $63
NASDAQ · Healthcare · Medical - Healthcare Information Services · Alpha Radar Sell · Power 38 · $1.4B mcap · 26M float · 4.48% daily turnover · Short 56% of daily vol

Cash Flow Trends

Operating Cash Flow
$33M +216.8% ▲
Capital Expenditures
$19M -246.3% ▼
5Y CAGR: -9.9%
Free Cash Flow
$14M +142.0% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$20M +236.8% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$245M-$549M-$176M-$52M-$21M
Depreciation & Amort.$22M$59M$36M$22M$25M
Stock-Based Comp.$219M$42M-$326K$9M$32M
Change in Working Capital$8M$36M-$38M-$25M-$16M
Other Non-Cash Items-$194M$142M-$721K$18M$13M
Operating Cash Flow-$190M-$319M-$180M-$28M$33M
— Investing Activities —
Capital Expenditures-$9M-$14M-$6M-$5M-$19M
Acquisitions (Net)$0-$127M-$8M$0-$33M
Investment Purchases$0$0-$48M-$66M-$56M
Investment Sales$0$0$18M$42M$46M
Other Investing-$11M$0$0$0$0
Investing Cash Flow-$21M-$141M-$44M-$30M-$62M
— Financing Activities —
Net Debt Issuance-$13M-$3M$43M-$3M-$4M
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$65M$3M$285K$891K$0
Financing Cash Flow$494M$197M$186M$44M$48M
Net Change in Cash$283M-$263M-$38M-$14M$20M
Cash End of Period$401M$138M$100M$86M$106M
Free Cash Flow-$211M-$333M-$186M-$34M$14M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms